Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
113
Total 13F shares, excl. options
40.3M
Shares change
+1.48M
Total reported value, excl. options
$654M
Value change
-$2.81M
Put/Call ratio
1.75
Number of buys
71
Number of sells
-46
Price
$16.24

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2022

147 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q1 2022.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 40.3M shares of 264M outstanding shares and own 15.24% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (7.18M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.4M shares), BlackRock Inc. (3.4M shares), Cederberg Capital Ltd (2.22M shares), MORGAN STANLEY (1.62M shares), Artisan Partners Limited Partnership (1.42M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.4M shares), Octagon Capital Advisors LP (1.05M shares), VANGUARD GROUP INC (1M shares), and BANK OF AMERICA CORP /DE/ (875K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.